Company
RelationRx
Relation is building a generational pharmaceutical company with AI at its core.
Also known as Relation, Relation Therapeutics Limited
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- London, United Kingdom
- Legal name
- Relation Therapeutics Limited
- relationrx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Founded on a biology-first approach, the company has developed proprietary AI and experimental platforms that drive deep mechanistic understanding of disease across the full drug development cycle, advancing programmes in bone, cardiorenal, dermatology and rheumatology.
Funding snapshot
- Total raised
- $116MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $26M2025-12-09
Funding rounds
- Round, 2025
- $26M2025-12-09, Company stated
- Round, 2025
- $36.2M2025-11-21, SEC form D sold, 5 investors
- Round, 2024
- $15M2024-11-22, SEC form D sold, 1 investor
- Round, 2024
- $40.3M2024-01-09, SEC form D sold, 10 investors
- Round, 2022
- $16M2022-05-19, SEC form D sold, 8 investors
- Round, 2021
- $9M2021-07-28, SEC form D sold, 10 investors
Products
- Web
- MORGAN
- Web
- Relation Development Platform
- Web
- Relation Discovery Platform
Loading relationship preview